Michael Mason, VP, Finance and Treasurer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 23,625 shares at $29.93 ($707K) on 2013-06-17, disclosed to the SEC on 2013-06-19.
Scheduled sale ($707k) by VP, Finance and Treasurer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.93 | 4,375 | $131K | 18.5% |
| 2 | $29.93 | 6,250 | $187K | 26.5% |
| 3 | $29.93 | 13,000 | $389K | 55.0% |
| Total | $29.93 avg | 23,625 | $707K | 100% |
| Filing → |
| KPTI | SELL | 2024-03-04 | $40K | — | Filing → |
| KPTI | SELL | 2024-02-29 | $3K | — | Filing → |
| KPTI | SELL | 2024-02-08 | $7K | — | Filing → |